Acadia Pharmaceuticals Inc
ACAD
Revenue
241.96M
▲36.13M▲17.55%
3 Months ChangeAssets
914.10M
▲59.00M▲6.90%
3 Months ChangeLiabilities
397.40M
▲6.34M▲1.62%
3 Months ChangeFree Cash Flow
-76.33M
▼-15.10M▼-24.67%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-23
Form 8-K
ID: 0001193125-24-223726
2024-08-07
Form 10-Q
ID: 0000950170-24-092163
2024-08-06
Form 8-K
ID: 0000950170-24-091826
2024-05-29
Form 8-K
ID: 0001193125-24-149336
2024-05-09
Form 10-Q
ID: 0000950170-24-056077
2024-05-08
Form 8-K
ID: 0000950170-24-055647
2024-03-11
Form 8-K
ID: 0001193125-24-064791
2024-02-27
Form 8-K
ID: 0000950170-24-021169
2024-01-31
Form 8-K
ID: 0001193125-24-019903
2023-11-21
Form 8-K
ID: 0001193125-23-281574